share_log
Breakings ·  Nov 5 22:15
Kite to Highlight Industry-Leading Car T-Cell Therapy Portfolio at Ash 2024, Including Positive Survival Outcomes in Both Clinical Trials and the Real-World
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment